Chinese Japanese Germany Korea


Description References
Carboplatin structure
Chemical Name:
Molecular Formula:
Formula Weight:
MOL File:

Carboplatin Properties

Melting point:
storage temp. 
Store at RT
Sparingly soluble in water, very slightly soluble in acetone and in ethanol (96 per cent).
Water Solubility 
Soluble in water.
Stable. Incompatible with strong oxidizing agents.
EPA Substance Registry System
Platinum, diammine[1,1-cyclobutanedi( carboxylato-.kappa.O)(2-)]-, (SP-4-2)-(41575-94-4)
  • Risk and Safety Statements
  • Hazard and Precautionary Statements (GHS)
Hazard Codes  T
Risk Statements  46-61-20/21/22-42/43-20/21
Safety Statements  53-22-26-36/37/39-45
RIDADR  2811
WGK Germany  3
RTECS  TP2300000
HS Code  28439000
Hazardous Substances Data 41575-94-4(Hazardous Substances Data)
Toxicity LD50 in mice (mg/kg): 150 i.p., 140 i.v.; in rats (mg/kg): 85 i.v. (Lelieveld)
Signal word: Danger
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H302 Harmful if swallowed Acute toxicity,oral Category 4 Warning P264, P270, P301+P312, P330, P501
H312 Harmful in contact with skin Acute toxicity,dermal Category 4 Warning P280,P302+P352, P312, P322, P363,P501
H315 Causes skin irritation Skin corrosion/irritation Category 2 Warning P264, P280, P302+P352, P321,P332+P313, P362
H317 May cause an allergic skin reaction Sensitisation, Skin Category 1 Warning P261, P272, P280, P302+P352,P333+P313, P321, P363, P501
H319 Causes serious eye irritation Serious eye damage/eye irritation Category 2A Warning P264, P280, P305+P351+P338,P337+P313P
H332 Harmful if inhaled Acute toxicity,inhalation Category 4 Warning P261, P271, P304+P340, P312
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled Sensitisation, respiratory Category 1 Danger P261, P285, P304+P341, P342+P311,P501
H340 May cause genetic defects Germ cell mutagenicity Category 1A, 1B Danger
H360 May damage fertility or the unborn child Reproductive toxicity Category 1A, 1B Danger
Precautionary statements:
P201 Obtain special instructions before use.
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P264 Wash hands thoroughly after handling.
P264 Wash skin thouroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P271 Use only outdoors or in a well-ventilated area.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P284 Wear respiratory protection.
P304+P340 IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P308+P313 IF exposed or concerned: Get medical advice/attention.
P405 Store locked up.
P501 Dispose of contents/container to..…

Carboplatin price More Price(15)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich 216100-M Carboplatin 41575-94-4 25mg-m $96.8 2018-11-20 Buy
Sigma-Aldrich 1096407 Carboplatin United States Pharmacopeia (USP) Reference Standard 41575-94-4 100mg $360.15 2018-11-13 Buy
TCI Chemical C2043 Carboplatin >98.0%(HPLC) 41575-94-4 1g $345 2018-11-22 Buy
TCI Chemical C2043 Carboplatin >98.0%(HPLC) 41575-94-4 100mg $66 2018-11-22 Buy
Alfa Aesar J60433 Carboplatin 41575-94-4 1g $362 2018-11-13 Buy

Carboplatin Chemical Properties,Uses,Production


Carboplatin (Brand name: Paraplatin) is a kind of chemotherapy medication used for the treatment of a series of cancers. It can be used for the treatment of various kinds of cancers including ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma. Moreover, it may also be used for treating some types of testicular cancer. Carboplatin belongs to a kind of alkylating agent. It takes effect through three major mechanisms: (1) Attach the alkyl groups to the DNA bases, further causing DNA fragmentation so that DNA replication is inhibited; (2) Cause DNA damage through inducing the formation of cross-links which prevents DNA from being separated for synthesis or transcription; (3) Induce mispairing of the nucleotides leading to mutations.



Carboplatin is a second generation, platinum-containing antineoplastic agent with significantly reduced nephro-, neuro-, and ototoxicity in comparison to cisplatin. It is effective in the treatment of advanced ovarian carcinoma of epithelial origin and small cell carcinoma of the lung.

Chemical Properties

White Crystals


Johnson Matthey (United Kingdom)




antitumor agent,


Analog of Cisplatin with reduced nephrotoxicity. Antineoplastic


Carboplatin (Paraplatin) is an analogue of cisplatin. Its plasma half-life is 3 to 5 hours, and it has no significant protein binding. Renal excretion is the major route of drug elimination.
Despite its lower chemical reactivity, carboplatin has antitumor activity that is similar to that of cisplatin against ovarian carcinomas, small cell lung cancers, and germ cell cancers of the testis. Most tumors that are resistant to cisplatin are cross-resistant to carboplatin.
The major advantage of carboplatin over cisplatin is a markedly reduced risk of toxicity to the kidneys, peripheral nerves, and hearing; additionally, it produces less nausea and vomiting. It is, however, more myelosuppressive than cisplatin. Other adverse effects include anemia, abnormal liver function tests, and occasional allergic reactions.

brand name

Paraplatin (Bristol-Myers Squibb).

General Description

Carboplatin is available in 50-, 150-, and 450-mg vials for IVadministration in the treatment of ovarian cancer, bladdercancer, germ cell tumors, head and neck cancers, small celllung cancer, and NSCLC. Activation of the agent occurs byaquation in a manner similar to that seen for cisplatin. Thepresence of the chelating 1,1-cyclobutane-dicarboxylateslows this reaction 100-fold and reduces the toxicity of theagent. The sites of alkylation and mechanisms of resistanceare like those seen for cisplatin, and the two agents showcross-resistance. The agent is widely distributed upon IV administration but, because of its greater stability, it bindsslowly to plasma proteins, requiring 24 hours to reach 90%bound drug compared with 4 hours for cisplatin. The agent iseliminated in the urine with a terminal elimination half-lifeof 2 to 6 hours. Adverse effects include myelosuppression,which is dose limiting. Other adverse effects include renaltoxicity, nausea, vomiting, and peripheral neuropathy, butthese occur much less frequently than with cisplatin.

Pharmaceutical Applications

Carboplatin, cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II), is a second-generation platinum drug. Its structure is based on cisplatin with the difference that the chloride ligands are exchanged for a bidentate chelating ligand. A consequence is that carboplatin is less reactive than cisplatin and therefore is less nephrotoxic and orthotoxic than the parent compound. Unfortunately, it is more myelosuppressive than cisplatin, which reduces the patients’ white blood cell count and makes them susceptible to infections. Carboplatin was licensed by the FDA in 1989 under the brand name Paraplatin and has since then gained worldwide recognition. Carboplatin on its own or in combination with other anticancer agents is used in the treatment of a variety of cancer types including head and neck, ovarian, small-cell lung, testicular cancer and others.
Carboplatin is a pale-white solid showing good aqueous solubility. The synthesis starts with potassium tetrachloroplatinate, which is reacted to the orange [PtI4]2- anion.

Biological Activity

Antitumor agent that forms platinum-DNA adducts. Causes intra- and interstrand DNA crosslinks blocking DNA replication and transcription. Enhances radiation-induced single-strand DNA breakage and displays lower nephrotoxicity than analog cisplatin (cis-Diaminodichloroplatinum ).

Veterinary Drugs and Treatments

Like cisplatin, carboplatin may be useful in a variety of veterinary neoplastic diseases including squamous cell carcinomas, ovarian carcinomas, mediastinal carcinomas, pleural adenocarcinomas, nasal carcinomas and thyroid adenocarcinomas. Carboplatin’s primary use currently in small animal medicine is in the adjunctive treatment (post amputation) of osteogenic sarcomas. Its effectiveness in treating transitional cell carcinoma of the bladder has been disappointing; however, carboplatin may have more efficacy against melanomas than does cisplatin.
Carboplatin, unlike cisplatin, appears to be relatively safe to use in cats.
Carboplatin may be considered for intralesional use in conditions such as equine sarcoids or in treating adenocarcinoma in birds.
Whether carboplatin is more efficacious than cisplatin for certain cancers does not appear to be decided at this point, but the drug does appear to have fewer adverse effects (less renal toxicity and reduced vomiting) in dogs.

Carboplatin Preparation Products And Raw materials

Raw materials

Preparation Products

Carboplatin Suppliers

Global( 307)Suppliers
Supplier Tel Fax Email Country ProdList Advantage
Henan DaKen Chemical CO.,LTD.
+86-371-55531817 CHINA 21759 58
Henan Tianfu Chemical Co.,Ltd.
0371-55170693 CHINA 20672 55
020-81716319 CHINA 2543 55
Hebei Chisure Biotechnology Co., Ltd.
0311 66567340 CHINA 1017 58
career henan chemical co
+86-371-86658258 CHINA 27142 58
TianYuan Pharmaceutical CO.,LTD
+86-755-23284190 13684996853
+86-755-23284190 CHINA 306 58
Jinan Jianfeng Chemical Co., Ltd
15562555968 CHINA 294 58
Shenzhen Nexconn Pharmatechs Ltd
15013857715 CHINA 3193 58
Chemwill Asia Co.,Ltd.
86-21-51861608;;; CHINA 23964 58
Hebei Jimi Trading Co., Ltd.
+86 017772612259 +86 319 5273535 CHINA 299 58

View Lastest Price from Carboplatin manufacturers

Image Release date Product Price Min. Order Purity Supply Ability Manufacturer
2019-07-03 Carboplatin
US $10.00 / KG 1KG 99% 10 mt Hebei Guanlang Biotechnology Co., Ltd.
2018-07-26 Carboplatin
US $100.00 / KG 1KG 98% 100KG career henan chemical co
2019-04-10 Carboplatin
US $1.00 / KG 1KG 99% 500kg Hebei Jimi Trading Co., Ltd.

Carboplatin Spectrum

41575-94-4(Carboplatin)Related Search:

Copyright 2017 © ChemicalBook. All rights reserved